causal

Real-world cancer patients fare worse than trial patients

Idealized clinical trials enroll younger, healthier patients with fewer comorbidities than real-world patients, so trial survival overstates real-world benefit; in some cases real-world patients on the active drug live half as long as control-arm patients on a sugar pill in the trial, meaning the true absolute benefit of these agents is even smaller than the published figures.

causalpending

Speaker

Vinay Prasad

Evidence Quote

“everything we know about idealized clinical trials is that the people on these clinical studies, they live longer than people in the real world”

Source

Vinay Prasad on Cancer Drugs, Medical Ethics, and Malignant— EconTalk
Created: 6/13/2026, 12:28:36 AM

Your notes

Loading notes...